We have known about Truvada for a while. Now, an influential advisory panel of the Food and Drug Administration has endorsed the drug shown to prevent HIV infection in healthy people. It recommended approval of the pill for people at risk of contracting the virus. A final decision is expected next month, but if FDA does approve, it won’t be without a degree of controversy. We’re joined by Dr. Kenneth Mayer, medical research director at Fenway Health in Boston and a professor at Harvard Medical School.
At The World, we believe strongly that human-centered journalism is at the heart of an informed public and a strong democracy. We see democracy and journalism as two sides of the same coin. If you care about one, it is imperative to care about the other.
Every day, our nonprofit newsroom seeks to inform and empower listeners and hold the powerful accountable. Neither would be possible without the support of listeners like you. If you believe in our work, will you give today? We need your help now more than ever!